|
|
|
|
|
Sponsored by: |
Christiana Care Health Services |
Information provided by: | Christiana Care Health Services |
ClinicalTrials.gov Identifier: | NCT00388830 |
The purpose of this study is to determine whether fasting for 8 hours prior to ultrasonography for cholelithiasis (gallbladder pain) is needed.
Condition | Intervention |
Gallbladder Diseases |
Procedure: Ultrasound |
MedlinePlus related topics: | Gallbladder Diseases Ultrasound |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Single Blind, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | "Emergency Bedside Ultrasonography of the Gallbladder: Does Fasting Matter?" |
Estimated Enrollment: | 70 |
Study Start Date: | May 2006 |
Study Completion Date: | July 2007 |
Ultrasonography of the gallbladder is currently the diagnostic modality of choice in determining cholelithiasis and cholecystitis. Historically this test has been performed in the Radiology suites where the patient was expected to fast for times of six to ten hours. Patients presenting to emergency departments (ED) have also been required to wait to have their study performed in order to have better visualization of the gallbladder. However, few studies have examined whether a fasting time matters in determining gallbladder pathology. Furthermore, with the emphasis on through-times in the ED, most EDs cannot afford holding their patients in the ED to wait for a test. Finally, with the advent of emergency bedside ultrasonography and the greater level of comfort emergency physicians (EP) have in diagnosing gallbladder pathology, it is possible to now determine an answer within minutes. We will test to see if EPs trained in the use of emergency bedside ultrasound can effectively and efficiently determine gallbladder pathology and if fasting has an impact on their ability to perform a quality ultrasound.
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Delaware | |||||
Christiana Care Health Services | |||||
Newark, Delaware, United States, 19718 |
Christiana Care Health Services |
Study Director: | Robert O'Connor, MD, MPH | Christiana Care Health Services |
Study ID Numbers: | 26046 |
First Received: | October 13, 2006 |
Last Updated: | October 5, 2007 |
ClinicalTrials.gov Identifier: | NCT00388830 |
Health Authority: | United States: Institutional Review Board |
|
|
|